Anemia and Low Body Mass Index in Axial Spondyloarthritis: Results from ChinaSpA, the Chinese Spondyloarthritis Registry
Tóm tắt
Từ khóa
Tài liệu tham khảo
Zhang S, Peng L, Li Q, et al. Spectrum of spondyloarthritis among Chinese populations. Curr Rheumatol Rep. 2022;24(8):247–58.
Cho SH, Lee H, Kwon H, et al. Association of underweight status with the risk of tuberculosis: a nationwide population-based cohort study. Sci Rep. 2022;12(1):16207.
de Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012;71(2):332–8.
Wilkinson M, Bywaters EG. Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases. Ann Rheum Dis. 1958;17(2):209–28.
Burgos-Vargas R, Naranjo A, Castillo J, Katona G. Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset. J Rheumatol. 1989;16(2):186–91.
Niccoli L, Nannini C, Cassarà E, Kaloudi O, Cantini F. Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes. Int J Rheum Dis. 2012;15(1):56–61.
Braun J, van der Heijde D, Doyle MK, et al. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab. Arthritis Rheum. 2009;61(8):1032–6.
Bes C, Yazici A, Soy M. Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis. Rheumatol Int. 2013;33(6):1415–8.
Zviahina OV, Shevchuk SV, Kuvikova IP, Segeda IS. Anemia in patients with ankylosing spondylitis, association with the activity of the inflammatory process and the severity of the disease. Wiad Lek. 2020;73(4):715–21.
World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894(i–xii):1–253.
Tan KC. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.
Rubio Vargas R, van den Berg R, van Lunteren M, et al. Does body mass index (BMI) influence the ankylosing spondylitis disease activity score in axial spondyloarthritis? Data from the space cohort. RMD Open. 2016;2(1):e000283.
Zhao J, Li J, Zheng W, Liu D, Sun X, Xu W. Low body mass index and blood loss in primary total hip arthroplasty: results from 236 consecutive ankylosing spondylitis patients. Biomed Res Int. 2014;2014: 742393.
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–7.
Fryar CD, Carroll MD, Afful J. Prevalence of underweight among adults aged 20 and over: United States, 1960–1962 through 2017–2018. NCHS Health E-Stats. 2020. https://www.cdc.gov/nchs/data/hestat/underweight-adult-17-18/underweight-adult.htm
Moore S, Hall JN, Harper S, Lynch JW. Global and national socioeconomic disparities in obesity, overweight, and underweight status. J Obesity. 2010;2010: 514674.
Yang L, Bovet P, Ma C, Zhao M, Liang Y, Xi B. Prevalence of underweight and overweight among young adolescents aged 12–15 years in 58 low-income and middle-income countries. Pediatr Obes. 2019;14(3):e12468.
Biswas T, Garnett SP, Pervin S, Rawal LB. The prevalence of underweight, overweight and obesity in Bangladeshi adults: data from a national survey. PLoS ONE. 2017;12(5):e0177395.
Gao B, Zhang L, Zhao M. Underweight but metabolically abnormal phenotype: metabolic features and its association with cardiovascular disease. Eur J Intern Med. 2016;29:46–51.
Song P, Man Q, Li Y, et al. Trends of underweight malnutrition among chinese residents aged 60 years and above—China, 1992–2015. China CDC Wkly. 2021;3(11):232–6.
Su J, Wang R, Duan X, et al. Clinical characteristics of axial spondyloarthritis patients in China: results from ChinaSpA, the Chinese spondyloarthritis registry. Clin Exp Rheumatol. 2022;40(3):544–50.
Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83.
Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 2003;62(2):127–32.
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286–91.
Lukas C, Landewé R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18–24.
Calin A, Jones SD, Garrett SL, Kennedy LG. Bath ankylosing spondylitis functional index. Br J Rheumatol. 1995;34(8):793–4.
Anaemias NU. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011. Contract No.: WHO/NMH/NHD/MNM/11.1.
Furst DE, Kay J, Wasko MC, et al. The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Rheumatology (Oxford). 2013;52(10):1845–55.
Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754–62.